Acquired haemophilia A (AHA) refers to a rare bleeding disorder caused by the production of specific inhibitors of endogenous coagulation factor VIII in patients with normal hemostatic function, leading to a decrease in plasma FVIII activity (1–3). This evidence concerns the gene F8 and hemorrhagic disease.